MedDataX Logo

A Study to Evaluate the Safety and Effectiveness of the 217z Laser With Zyoptix for Lasik

NCT ID: NCT00347997

Last Updated: 2011-12-08

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

WITHDRAWN

Clinical Phase

NA

Study Classification

INTERVENTIONAL

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

A Study to demonstrate the safety and efficacy of wavefront laser refractive surgery treatments for myopia and astigmatism.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Myopia Astigmatism

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

SINGLE_GROUP

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

LASIK

LASIK correction of myopia and myopic astigmatism

Group Type EXPERIMENTAL

217z Laser

Intervention Type DEVICE

LASIK correction of myopia and myopic astigmatism

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

217z Laser

LASIK correction of myopia and myopic astigmatism

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Myopia with or without astigmatism.

Exclusion Criteria

* Contraindications to LASIK.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Bausch & Lomb Incorporated

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Mohinder Merchea, OD, PhD

Role: STUDY_DIRECTOR

Bausch & Lomb Incorporated

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

385

Identifier Type: -

Identifier Source: org_study_id